Evidence map›Paper›PMID 42181166›Full record

ArticleEnvironmental research communications2026

Exceptional use: examining methyl bromide applications in California 2016-2022.

Yoshira Ornelas Van Horne, Jill E Johnston

Abstract read
In one paragraph

Article in Environmental research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yoshira Ornelas Van HorneDepartment of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA 90095, United States of America.ORCID https://orcid.org/0000-0001-7203-5825
Jill E JohnstonDepartment of Environmental and Occupation Health, Joe C. Wen School of Population and Public Health, University of California Irvine, Irvine, CA 92697, United States of America.ORCID https://orcid.org/0000-0002-4530-0555

Funding

Translation CoreP2CES033433 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Jill E Johnston, Elizabeth Mary Kamai · 2022 to 2026
$4.9M
NIEHS NIH HHS P2C ES033433
6 · The paper itself

Abstract

Methyl bromide (MeBr) has been widely used as a fumigant to control for pests, fungi and weeds as well as for disinfection of warehouses, shipping containers, and other commodities. MeBr is a known developmental, neurologic and respiratory toxin. Due to its ozone-depleting properties, MeBr was listed under the Montreal Protocol in 1992. While MeBr use was set to phase out by 2005, the Montreal Protocol and the US Clean Air Act allows critical use exemptions, such as fumigation of freight containers for quarantine and preshipment purposes. To evaluate state-wide spatial and temporal patterns, we examine publicly available pesticide data on the use of MeBr in California from 2016-2022. We found that MeBr applications continue in 36 out of 58 CA counties. For non-agricultural fumigation applications (e.g., commodity fumigation) of MeBr from 2016-2022, a total of 582,050 kilograms (1,283,201 pounds) were applied across 25 counties in CA, home to 24 million people. Los Angeles ranks as the highest use county, with a total of 269,571 or 46% of the total kilograms (594,302 pounds) applied from 2016-2022 for non-agricultural fumigation applications. Additionally, we characterized ambient MeBr concentrations in the West Long Beach community of LA County, based on a state monitor active since 2023, observing concentrations exceeding CA standards. This study underscores the importance of evaluating chemical phaseouts and improving enforcement and monitoring to ensure public health protections.

Indexed as

enforcementfumigationmethyl bromidepesticides

Identifiers

PMID42181166
PMCPMC13193060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.